Extend Biosciences
Pre-clinicalDevelops novel therapeutics using proprietary technology to extend the half-life of peptides and proteins for improved treatment of metabolic and endocrine disorders.
Founded
2009
Focus
Drug Delivery
About
Develops novel therapeutics using proprietary technology to extend the half-life of peptides and proteins for improved treatment of metabolic and endocrine disorders.
Funding History
2Total raised: $21M
Series A$15MUndisclosedAug 15, 2023
Seed$6MUndisclosedMay 15, 2021
Company Info
TypePrivate
Founded2009
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile